Austria vs Latvia: Share of S. aureus infections resistant to methicillin
Austria
3.9%
in 2022
Latvia
3.8%
in 2022
Austria rank
40th
Latvia rank
41st
Share of S. aureus infections resistant to methicillin over time
- Austria
- Latvia
How they compare
Austria currently reports 3.9% against 3.8% in Latvia, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Austria ahead.
Austria ranks 40th and Latvia ranks 41st of 45 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Austria | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.9% | 6.6% | 0.7% | Latvia |
| 2020s | 3.8% | 7.3% | 3.5% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Austria or Latvia?
- Austria, at 3.9% against 3.8% in Latvia as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Austria and Latvia?
- 0.1%, with Austria ahead.
- How many years of comparable data are there for Austria and Latvia?
- 6 years are reported by both, from 2017 to 2022.
- How do Austria and Latvia rank globally for share of s. aureus infections resistant to methicillin?
- Austria ranks 40th and Latvia ranks 41st of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).